Have you been diagnosed with Chronic  Pancreatitis?  We are currently working on a research study  using an Investigational drug that is being  evaluated to treat patients who have been  diagnosed with Chronic Pancreatitis (CP).  The purpose of this study (double‐blind  phase) is to determine how well the  Investigational drug works in controlling pain  associated with this disease; determine the  pharmacokinetics (PK) (drug levels of the  Investigational drug); and how safe the drug  is when taking three doses of NI‐03 (100 mg,  200 mg and 300 mg) when taken three times  daily for 28 consecutive days (4 weeks)  compared to placebo (sugar pill) also taken in  the same manner.

Chronic Pancreatitis clinical trial now enrolling near you. See if you qualify today.
ClinicalTrials.gov Study Details
Chronic Pancreatitis
A phase 1, single dose pk and safety study with NI-03 followed by a phase 2, randomized, double-blind, parallel-group dose-ranging study to evaluated the safety and efficacy of NI-03 compared to placebo in subjects and efficacy of NI-03 compared to placebo in subjects with chronic pancreatitis